Cancer-associated genodermatoses-Reference-Cited by-同舟云学术

Cancer-associated genodermatoses

Published:2022-08-15 Issue:2 Volume:9 Page:60-74
ISSN:2413-5496
Container-title:Russian Journal of Pediatric Hematology and Oncology
language:
Short-container-title:Ross. ž. det. gematol. onkol.

Author:

Belysheva T. S.¹^ORCID,Nasedkina T. V.²^ORCID,Semenova V. V.³^ORCID,Kozlova V. M.¹^ORCID,Sharapova E. V.¹^ORCID,Mikhailova S. N.¹^ORCID,Valiev T. T.¹^ORCID,Varfolomeeva S. R.¹^ORCID

Affiliation:

1. N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia

2. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

3. N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

Abstract

Genodermatoses are a heterogeneous group of hereditary diseases that are characterized by predominantly skin lesions. To date, there are more than 200 genetically determined skin diseases, representing about 35 % of all hereditary syndromes. In some cases, skin lesions may be the only manifestation of the disease, but still more often, they occur in combination with disorders of other organ systems. In many cases, genodermatoses are associated with an increased risk of malignancy which makes early detection of hereditary syndromic pathology especially important for cancer prevention.This review provides a brief description of the dermatological manifestations as well as other phenotypic features of a number of genodermatoses, their genetic nature, and the strategy of management.

Publisher

OOO Grafika

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference92 articles.

1. Lehmann A.R., McGibbon D., Stefanini M. Xeroderma pigmentosum. Orphanet J Rare Dis. 2011;6:70. doi: 10.1186/1750-1172-6-70.

2. Nishigori C., Nakano E., Masaki T., Ono R., Takeuchi S., Tsujimoto M., Ueda T. Characteristics of Xeroderma Pigmentosum in Japan: Lessons From Two Clinical Surveys and Measures for Patient Care. Photochem Photobiol. 2019;95(1):140–53. doi: 10.1111/php.13052.

3. Mareddy S., Reddy J., Babu S., Balan P. Xeroderma pigmentosum: man deprived of his right to light. Scientifi cWorldJournal. 2013;2013:534752. doi: 10.1155/2013/534752.

4. Feltes B.C., Bonatto D. Overview of xeroderma pigmentosum proteins architecture, mutations and post-translational modifi cations. Mutat Res Rev Mutat Res. 2015;763:306–20. doi: 10.1016/j.mrrev.2014.12.002.

5. Bradford P.T., Goldstein A.M., Tamura D., Khan S.G., Ueda T., Boyle J., Oh K.S., Imoto K., Inui H., Moriwaki S., Emmert S., Pike K.M., Raziuddin A., Plona T.M., DiGiovanna J.J., Tucker M.A., Kraemer K.H. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet. 2011;48(3):168–76. doi: 10.1136/jmg.2010.083022.